SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-012440
Filing Date
2018-05-09
Accepted
2018-05-09 16:25:26
Documents
3
Period of Report
2018-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20180509.htm 8-K 28049
2 EX-99.1 vktx-ex991_6.htm EX-99.1 237324
3 GRAPHIC g201805091942559193727.jpg GRAPHIC 4765
  Complete submission text file 0001564590-18-012440.txt   273218
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 18818659
SIC: 2834 Pharmaceutical Preparations